Natural Alternatives International Q4 sales rise on royalty income
NAII•Fiscal Q4 sales rose 1.9% year over year to $34.51 million, while the company reported a $13.54 million net loss that included a $10.4 million non-cash impairment charge. It is consolidating U.S. manufacturing and exploring strategic alternatives, including a possible sale.
1. Quarterly results and plans
Natural Alternatives International said fiscal Q4 sales rose 1.9% year over year to $34.51 million. Net loss was $13.54 million, including a $10.4 million non-cash impairment charge for its underutilized Carlsbad, California, facility. CarnoSyn revenue rose 22%, while private-label contract manufacturing sales increased 0.6%. The company plans to consolidate U.S. manufacturing at its Vista, California, facility and is exploring strategic alternatives, including a possible merger, acquisition or sale.
